vitiligo

A chessboard with blocks that read MA
Biotech

Argenx acquires Forte for $2.2B for ph.2-stage vitiligo drug

Argenx is spending $2.2 billion to absorb Forte Biosciences for its phase 2-stage vitiligo and celiac disease drug.
James Waldron , Angus Liu Jul 27, 2026 6:08am
layoffs cuts workforce reduction chairs boxes fired

Australia's Clinuvel to shed up to 20% of workforce in US move

Jul 23, 2026 5:47am
Completing steps towards success checkmark on cubes symbolizing progress

Racing Takeda, InnoCare reports TYK2 inhibitor win in vitiligo

Jul 16, 2026 9:36am
photo of a pair of hands that show the skin condition vitiligo

Incyte’s vitiligo bet scores ph. 3 wins but can’t shake off Rinvoq

Apr 28, 2026 9:52am
king crown queen royalty monarchy gold winner top

Teva lines up $500M in Royalty Pharma funding for vitiligo drug

Jan 12, 2026 7:10am
pipeline pipes RD research

Incyte scraps BET inhibitor and anti-CD122 drug

Oct 28, 2025 9:05am